top of page

XEVOLAC SOLUTION FOR INJECTION 30 MG/ML

Product details

Registration number: SIN16401P

Classification: Prescription Only

Active ingredients: Ketorolac Trometamol

Strength: 30 mg/ml

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR; INTRAVENOUS BOLUS

Registrant: NOVEM HEALTHCARE PTE LTD

ATC code: M01AB15

HSA approval date: 14 December 2021

Manufacturer(s): PT. Novell Pharmaceutical Laboratories

Manufacturing country/countries: INDONESIA REP OF

What are the HSA registration number and classification for XEVOLAC SOLUTION FOR INJECTION 30 MG/ML?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16401P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for XEVOLAC SOLUTION FOR INJECTION 30 MG/ML?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Ketorolac Trometamol

Strength: 30 mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for XEVOLAC SOLUTION FOR INJECTION 30 MG/ML?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, SOLUTION

Route: INTRAMUSCULAR; INTRAVENOUS BOLUS

Source for this answer

Who is the recorded registrant for XEVOLAC SOLUTION FOR INJECTION 30 MG/ML?

According to the HSA dataset updated 7 August 2026:

Registrant: NOVEM HEALTHCARE PTE LTD

Source for this answer

Which manufacturers and countries are listed for XEVOLAC SOLUTION FOR INJECTION 30 MG/ML?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): PT. Novell Pharmaceutical Laboratories

Manufacturing country/countries: INDONESIA REP OF

Source for this answer

Where can I look up XEVOLAC SOLUTION FOR INJECTION 30 MG/ML in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16401P or the exact product name XEVOLAC SOLUTION FOR INJECTION 30 MG/ML. The general register link does not preselect this product.

Source for this answer

What are the source dates for this XEVOLAC SOLUTION FOR INJECTION 30 MG/ML record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this XEVOLAC SOLUTION FOR INJECTION 30 MG/ML record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16401P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page